申请人:KASHIV BIOSCIENCES, LLC
公开号:US20210253626A1
公开(公告)日:2021-08-19
The present invention relates to fulvestrant prodrugs of formula II and process for the preparation thereof. The present disclosure also relates to pharmaceutical composition of fulvestrant prodrugs and method of treatment using the same.